Determinants of cardiac tyrosine hydroxylase activity during exercise- induced sympathetic activation in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Eisenhofer, Graeme ^a,c   Rundqvist, Bengt ^b   Friberg, Peter ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Dihydroxyphenylalanine; Norepinephrine; Sympathetic nerves; Transmitter turnover

Indexed keywords

DOPA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BICYCLE ERGOMETRY; HEART; HORMONE METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0031897418     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.3.r626     Document Type: Article

References (32)

1. Devalon, M. L., T. D. Miller, R. W. Squires, P. J. Rogers, A. A. Bove, and G. M. Tyce. Dopa in plasma increases during acute exercise and after exercise training. J. Lab. Clin. Med. 114: 321-327, 1989.
2. Eisenhofer, G. Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats. Naunyn Schmiedebergs Arch. Pharmacol. 349: 259-269, 1994.
3. Eisenhofer, G., M. D. Esler, I. T. Meredith, A. Dart, R. O. Cannon III, A. A. Quyyumi, G. Lambert, J. Chin, G. L. Jennings, and D. S. Goldstein. Sympathetic nervous function in the human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation 85: 1775-1785, 1992.
4. Eisenhofer, G., P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996.
5. Eisenhofer, G., D. S. Goldstein, and I. J. Kopin. Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal reuptake in vivo. Clin. Sci. (Colch.) 76: 171-182, 1989.
6. Eisenhofer, G., D. S. Goldstein, T. G. Ropchak, and I. J. Kopin. Source and physiological significance of plasma 3,4-dihydroxyphenylalanine in the rat. J. Neurochem. 51: 1204-1213, 1988.
7. Eisenhofer, G., I. T. Meredith, C. Ferrier, H. S. Cox, G. Lambert, G. L. Jennings, and M. D. Esler. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J. Lab. Clin. Med. 117: 266-273, 1991.
8. Eisenhofer, G., B. Rundqvist, A. Aneman, P. Friberg, N. Dakak, I. J. Kopin, M. C. Jacobs, and J. W. Lenders. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J. Clin. Endocrinol. Metab. 80: 3009-3017, 1995.
9. Eisenhofer, G., J. J. Smolich, H. S. Cox, and M. D. Esler. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog. Circulation 84: 1354-1363, 1991.
10. Eisenhofer, G., J. J. Smolich, and M. D. Esler. Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs. Neurochem. Int. 21: 37-44, 1992.
11. Eisenhofer, G., J. J. Smolich, and M. D. Esler. Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog. Naunyn Schmiedebergs Arch. Pharmacol. 345: 160-171, 1992.
12. Esler, M. D., G. Jennings, P. Korner, I. Willett, F. Dudley, G. Hasking, W. Anderson, and G. Lambert. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11: 3-20, 1988.
13. Esler, M. D., G. Wallin, P. K. Dorward, G. Eisenhofer, R. Westerman, I. Meredith, G. Lambert, H. S. Cox, and G. Jennings. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R817-R823, 1991.
14. Floor, E., P. S. Leventhal, Y. Wang, L. Meng, and W. Chen. Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J. Neurochem. 64: 689-699, 1995.
15. Garty, M., A. Deka-Starosta, P. C. Chang, G. Eisenhofer, Z. Zukowska-Grojec, R. Stull, I. J. Kopin, and D. S. Goldstein. Plasma levels of catechols during reflexive changes in sympathetic nerve activity. Neurochem. Res. 14: 523-531, 1989.
16. Goldstein, D. S., R. O. Cannon, A. Quyyumi, P. Chang, M. Duncan, J. E. Brush, Jr., and G. Eisenhofer. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J. Auton. Nerv. Syst. 34: 17-35, 1991.
17. Goldstein, D. S., C. Holmes, R. O. Cannon III, G. Eisenhofer, and I. J. Kopin. Sympathetic cardioneuropathy in dysautonomias. N. Engl. J. Med. 336: 696-702, 1997.
18. Goldstein, D. S., R. Udelsman, G. Eisenhofer, R. Stull, H. R. Keiser, and I. J. Kopin. Neuronal source of plasma dihydroxyphenylalanine. J. Clin. Endocrinol. Metab. 64: 856-861, 1987.
19. Gordon, R., S. Spector, A. Sjoerdsma, and S. Udenfriend. Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J. Pharmacol. Exp. Ther. 153: 440-447, 1966.
20. Grossman, E., A. Hoffman, I. Armando, Z. Abassi, I. J. Kopin, and D. S. Goldstein. Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats. Clin. Sci. (Colch.) 83: 65-74, 1992.
21. Kaye, D. M., M. Esler, B. Kingwell, G. McPherson, D. Esmore, and G. Jennings. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 88: 1110-1118, 1993.
22. Kvetnansky, R., I. Armando, V. K. Weise, C. Holmes, K. Fukuhara, A. Deka-Starosta, I. J. Kopin, and D. S. Goldstein. Plasma DOPA responses during stress: dependence on sympathoadrenal activity and tyrosine hydroxylation. J. Pharmacol. Exp. Ther. 261: 899-909, 1992.
23. Lenders, J. W. M., G. Eisenhofer, I. Armando, H. R. Keiser, D. S. Goldstein, and I. J. Kopin. Determination of plasma metanephrines by liquid chromatography with electrochemical detection. Clin. Chem. 39: 97-103, 1993.
24. Linnoila, M., F. Karoum, H. M. Calil, I. J. Kopin, and W. Z. Potter. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. Arch. Gen. Psychiatry 39: 1025-1028, 1982.
25. Maas, J. W., H. Benensohn, and D. H. Landis. A kinetic study of the disposition of circulating norepinephrine in normal male subjects. J. Pharmacol. Exp. Ther. 174: 381-387, 1970.
26. Marley, P. D., K. A. Thomson, and R. A. Bralow. Protein kinase A and nicotinic activation of bovine adrenal tyrosine hydroxylase. Br. J. Pharmacol. 114: 1687-1693, 1995.
27. Mazzeo, R. S. Catecholamine responses to acute and chronic exercise. Med. Sci. Sports Exerc. 23: 839-845, 1991.
28. Medvedev, O. S., M. D. Esler, J. A. Angus, H. S. Cox, and G. Eisenhofer. Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch. Pharmacol. 341: 192-199, 1990.
29. Meredith, I. T., M. D. Esler, H. S. Cox, G. W. Lambert, G. L. Jennings, and G. Eisenhofer. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin. Auton. Res. 1: 187-194, 1991.
30. Nagatsu, T. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays Biochem. 30: 15-35, 1995.
31. Rundquist, B., G. Eisenhofer, N. A. Dakak, M. Elam, F. Waagstein, and P. Friberg. Cardiac noradrenergic function one year following cardiac transplantation. Blood Press. 2: 252-261, 1993.
32. Zavadil, A. P., R. J. Ross, H. M. Calil, M. Linnoila, P. Blombery, D. C. Jimerson, I. J. Kopin, and W. Z. Potter. The effect of desmethylimipramine on the metabolism of norepinephrine. Life Sci. 35: 1061-1068, 1984.